Hair Growth Drug Safe at Low Doses for Breast Cancer Patients
NEW YORK, Dec. 9, 2024 /PRNewswire/ — Hair loss during chemotherapy can cause enough distress for some women to lose self-confidence, which experts say may discourage them from seeking chemotherapy in the first place. Oral minoxidil is a commonly prescribed treatment for hair loss. The drug is
State Grid Kizilsu Kirghiz Autonomous Prefecture Electric Power Supply Company actively provides services to ensure the safe and stable electricity consumption of heating enterprises.
ARTUSH, China, Dec. 9, 2024 /PRNewswire/ — Recently, the State Grid Kizilsu Kirghiz Autonomous Prefecture Electric Power Supply Company actively responded to the demand for winter heating, went deep into Meijia Thermal Power Co., Ltd. in Aheqi County to conduct a safe electricity inspection t
The U.S. Department of Homeland Security, Israel’s National Cyber Directorate, and the BIRD Foundation, Announce a Cybersecurity Call for Proposals
Approved projects will be awarded funding up to $1.5M TEL AVIV, Israel and WASHINGTON, Dec. 9, 2024 /PRNewswire/ — The U.S. Department of Homeland Security (DHS) Science and Technology Directorate (S&T), the Israel National Cyber Directorate (INCD), and the Israel-U.S. Binational Industr
Ballard to Supply 8 MW of Fuel Cell Engines to Stadler for Californian Passenger Rail
VANCOUVER, BC, Dec. 9, 2024 /PRNewswire/ – Ballard Power Systems (NASDAQ: BLDP) (TSX: BLDP) today announced the signing of a multi-year supply agreement with Stadler US (“Stadler”; www.stadlerrail.com) to supply 8 megawatts of FCmove®-HD+ fuel cell engines to power trains for the
Concord Healthcare Announces Approval Granted to the Application for the Proton Therapy Equipment Registration Certificate
BEIJING, Dec. 9, 2024 /PRNewswire/ — Concord Medical Services Holdings Limited (“Concord Medical” or the “Company”) (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that the National Medica
ADC Therapeutics Announces The Lancet Haematology Publication of Data from Investigator-Initiated Trial Evaluating ZYNLONTA® in Combination with Rituximab to Treat Relapsed/Refractory Follicular Lymphoma
Publication follows oral presentation at the American Society of Hematology (ASH) Annual Meeting Combination in r/r follicular lymphoma shows best ORR of 97% and CR rate of 77% with 12-month PFS of 95% Additional IIT data also presented at ASH on ZYNLONTA monotherapy in marginal zone lymphoma shows
Syndax Announces Additional Positive Data for Revuforj® (revumenib) from AUGMENT-101 Trial in Relapsed or Refractory mNPM1 AML and BEAT AML Frontline Combination Trial
– Subgroup analyses from Ph 2 protocol-defined R/R mNPM1 AML efficacy population (N=64) show responses across all major subgroups, including heavily pretreated patients – – 26% CR+CRh (20/77) and 48% ORR (37/77) in all enrolled patients who met the efficacy evaluable criteria in Ph 2 R/R mNPM
Endo Receives U.S. FDA Approval of Manufacturing Facility in Indore, India
20,000-square-foot site increases Endo’s sterile injectable production capacity This marks the site’s first U.S. FDA approval Endo is investing and innovating in its Injectable Solutions business MALVERN, Pa., Dec. 9, 2024 /PRNewswire/ — Endo, Inc. (OTCQX: NDOI) announced today tha
Mason Capital Management-Led Consortium Completes Acquisition of CB&I
All-cash equity transaction positions CB&I for long-term growth THE WOODLANDS, Texas, Dec. 9, 2024 /PRNewswire/ — CB&I, the world’s foremost designer and builder of storage facilities, tanks and terminals for energy and industrial markets, today announced the completion of its ac
PAINTEQ SECURES GROUNDBREAKING PATENT FOR LINQ® TECHNOLOGY, ADVANCING PRECISION AND EFFICIENCY IN SI JOINT FUSION
New Patent Adds Significant Protections to PainTEQ’s Instrumentation and Reinforces Its Leadership Position in Minimally Invasive SI Joint Dysfunction Treatment TAMPA, Fla., Dec. 9, 2024 /PRNewswire/ — PainTEQ, a leader in minimally invasive sacroiliac (SI) joint dysfunction treatment,
